|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-9-23
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of cisplatin/etoposide continuous infusion chemotherapy for cancer of unknown primary site in Taiwan, a region with a high prevalence of endemic viral infections.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
431-5
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9739784-Adult,
pubmed-meshheading:9739784-Aged,
pubmed-meshheading:9739784-Aged, 80 and over,
pubmed-meshheading:9739784-Alopecia,
pubmed-meshheading:9739784-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9739784-Carrier State,
pubmed-meshheading:9739784-Cisplatin,
pubmed-meshheading:9739784-Drug Administration Schedule,
pubmed-meshheading:9739784-Etoposide,
pubmed-meshheading:9739784-Female,
pubmed-meshheading:9739784-Hepatitis B,
pubmed-meshheading:9739784-Hepatitis C,
pubmed-meshheading:9739784-Humans,
pubmed-meshheading:9739784-Infusions, Intravenous,
pubmed-meshheading:9739784-Leukopenia,
pubmed-meshheading:9739784-Male,
pubmed-meshheading:9739784-Middle Aged,
pubmed-meshheading:9739784-Neoplasms, Unknown Primary,
pubmed-meshheading:9739784-Taiwan,
pubmed-meshheading:9739784-Thrombocytopenia,
pubmed-meshheading:9739784-Virus Diseases
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.
|
|
pubmed:affiliation |
Division of Cancer Research, National Health Research Institutes, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article
|
